Sigma-Aldrich

September 26, 2017

The Future of BioManufacturing: Cell Line Engineering

June 23, 2015
Merck Acquisition of Sigma-Aldrich receives conditional clearance from European Commission

Merck Acquisition of Sigma-Aldrich receives conditional clearance from European Commission

Sigma-Aldrich’s acquisition by Merck has been conditionally cleared by the European Commission, and has received full clearance from the Chinese Ministry of Commerce. Merck and Sigma […]
May 7, 2015
Sigma-Aldrich Announce Q1 2015 Sales Figures

Sigma-Aldrich Announce Q1 2015 Sales Figures

Sigma-Aldrich Corporation have posted strong Q1 2015 results ahead of their planned merger with Merck later this year. Sigma reported quarterly sales of $676 million, with […]
April 22, 2015
Merck appoints Udit Batra to head combined life science business ahead of Sigma-Aldrich acquisition

Merck appoints Udit Batra to head combined life science business ahead of Sigma-Aldrich acquisition

Udit Batra has been appointed to lead the combined life science business of Merck Millipore and Sigma-Aldrich once the acquisition of Sigma-Aldrich has been successfully completed […]
April 18, 2015
Sigma-Aldrich Launch New APAC Headquarters and Cell Culture Technical Center

Sigma-Aldrich Launch New APAC Headquarters and Cell Culture Technical Center

Global Life Science and High Technology company Sigma-Aldrich announced the opening of their new Asia Pacific headquarters and state-of-the-art Cell Culture Technical Center at the Biopolis […]
February 12, 2015
Sigma Reports Record Full-Year 2014 Sales

Sigma-Aldrich Reports Record Full-Year 2014 Sales

Sigma-Aldrich (NASDAQ – SIAL) Reports Record Full-Year 2014 Sales Of $2.79 Billion And Record Adjusted Diluted EPS Of $4.37. Reports Q4 2014 Adjusted Diluted EPS Of […]
November 6, 2014

BioReliance Introduce Advanced In Vitro ADME and Toxicology Services

BioReliance® Introduces Advanced In Vitro ADME and Toxicology Services Designed to Improve Drug Safety and Efficacy BioReliance® (www.bioreliance.com), Sigma-Aldrich Corporation’s (NASDAQ: SIAL) biologics and early-development services […]
November 4, 2014

Merck Millipore to Acquire Sigma-Aldrich

Merck to Acquire Sigma-Aldrich to Enhance Position in Attractive Life Science Industry Merck to acquire Sigma-Aldrich for $140 per share in cash, valuing company at approx. […]
October 29, 2014

Sigma-Aldrich Post Q3 2014 Results

Sigma-Aldrich (NASDAQ – SIAL) Reports Q3 2014 Results With Sales Of $690 Million And Adjusted Diluted EPS Of $1.06. Declares $0.23 Per Share Quarterly Dividend. Q3 […]
Contact Us